These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia. Grasl-Kraupp B; Rossmanith W; Ruttkay-Nedecky B; Müllauer L; Kammerer B; Bursch W; Schulte-Hermann R Hepatology; 1998 Sep; 28(3):717-26. PubMed ID: 9731564 [TBL] [Abstract][Full Text] [Related]
6. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
7. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B. Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894 [TBL] [Abstract][Full Text] [Related]
9. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis. Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825 [TBL] [Abstract][Full Text] [Related]
10. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892 [TBL] [Abstract][Full Text] [Related]
11. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1. Picon A; Gold LI; Wang J; Cohen A; Friedman E Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of angiogenesis related proteins and its implication in type-2 hereditary hemorrhagic telangiectasia]. Peng HL; Hu GY; Zhang GS; Gong FJ Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):616-20. PubMed ID: 17278429 [TBL] [Abstract][Full Text] [Related]
13. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts. Ylä-Outinen H; Aaltonen V; Björkstrand AS; Hirvonen O; Lakkakorpi J; Vähä-Kreula M; Laato M; Peltonen J J Invest Dermatol; 1998 Mar; 110(3):232-7. PubMed ID: 9506441 [TBL] [Abstract][Full Text] [Related]
15. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected]. Kirmaz C; Terzioglu E; Topalak O; Bayrak P; Yilmaz O; Ersoz G; Sebik F Eur Cytokine Netw; 2004; 15(2):112-6. PubMed ID: 15319169 [TBL] [Abstract][Full Text] [Related]
16. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells. Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216 [TBL] [Abstract][Full Text] [Related]
17. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma. Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884 [TBL] [Abstract][Full Text] [Related]
18. Circulating angiogenic cytokines in multiple myeloma and related disorders. Urba ska-Rys H; Wierzbowska A; Robak T Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213 [TBL] [Abstract][Full Text] [Related]
19. Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parameters. Sinnreich O; Kratzsch J; Reichenbach A; Gläser C; Huse K; Birkenmeier G Prostate; 2004 Nov; 61(3):201-8. PubMed ID: 15368477 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Masi L; Malentacchi C; Campanacci D; Franchi A Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]